133 related articles for article (PubMed ID: 30266507)
1. Hospitalization for Respiratory Syncytial Virus in Children with Down Syndrome Less than 2 Years of Age: A Systematic Review and Meta-Analysis.
Mitra S; El Azrak M; McCord H; Paes BA
J Pediatr; 2018 Dec; 203():92-100.e3. PubMed ID: 30266507
[TBL] [Abstract][Full Text] [Related]
2. Acute Lower Respiratory Infections Associated With Respiratory Syncytial Virus in Children With Underlying Congenital Heart Disease: Systematic Review and Meta-analysis.
Chaw PS; Wong SWL; Cunningham S; Campbell H; Mikolajczyk R; Nair H;
J Infect Dis; 2020 Oct; 222(Suppl 7):S613-S619. PubMed ID: 31599958
[TBL] [Abstract][Full Text] [Related]
3. Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infections in Children With Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis.
Chaw PS; Hua L; Cunningham S; Campbell H; Mikolajczyk R; Nair H;
J Infect Dis; 2020 Oct; 222(Suppl 7):S620-S627. PubMed ID: 31825072
[TBL] [Abstract][Full Text] [Related]
4. Children with Down syndrome are high-risk for severe respiratory syncytial virus disease.
Stagliano DR; Nylund CM; Eide MB; Eberly MD
J Pediatr; 2015 Mar; 166(3):703-9.e2. PubMed ID: 25596098
[TBL] [Abstract][Full Text] [Related]
5. Down Syndrome and the Risk of Severe RSV Infection: A Meta-analysis.
Beckhaus AA; Castro-Rodriguez JA
Pediatrics; 2018 Sep; 142(3):. PubMed ID: 30093540
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for respiratory syncytial virus hospitalisation in children with heart disease.
Kristensen K; Stensballe LG; Bjerre J; Roth D; Fisker N; Kongstad T; Svendsen AL; Nielsen BW
Arch Dis Child; 2009 Oct; 94(10):785-9. PubMed ID: 19541682
[TBL] [Abstract][Full Text] [Related]
7. Respiratory syncytial virus prophylaxis in Down syndrome: a prospective cohort study.
Yi H; Lanctôt KL; Bont L; Bloemers BL; Weijerman M; Broers C; Li A; Kiss A; Mitchell I; Paes B;
Pediatrics; 2014 Jun; 133(6):1031-7. PubMed ID: 24799541
[TBL] [Abstract][Full Text] [Related]
8. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group.
Pediatrics; 1997 Jan; 99(1):93-9. PubMed ID: 8989345
[TBL] [Abstract][Full Text] [Related]
9. Down's syndrome is a risk factor for severe lower respiratory tract infection due to respiratory syncytial virus.
Galleguillos C; Galleguillos B; Larios G; Menchaca G; Bont L; Castro-Rodriguez JA
Acta Paediatr; 2016 Nov; 105(11):e531-e535. PubMed ID: 27537430
[TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.
Rodriguez WJ; Gruber WC; Welliver RC; Groothuis JR; Simoes EA; Meissner HC; Hemming VG; Hall CB; Lepow ML; Rosas AJ; Robertsen C; Kramer AA
Pediatrics; 1997 Mar; 99(3):454-61. PubMed ID: 9041304
[TBL] [Abstract][Full Text] [Related]
11. Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses.
Friedman D; Fryzek J; Jiang X; Bloomfield A; Ambrose CS; Wong PC
PLoS One; 2017; 12(3):e0172512. PubMed ID: 28253361
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children.
Andabaka T; Nickerson JW; Rojas-Reyes MX; Rueda JD; Bacic Vrca V; Barsic B
Cochrane Database Syst Rev; 2013 Apr; (4):CD006602. PubMed ID: 23633336
[TBL] [Abstract][Full Text] [Related]
13. Down syndrome and hospitalizations due to respiratory syncytial virus: a population-based study.
Zachariah P; Ruttenber M; Simões EA
J Pediatr; 2012 May; 160(5):827-31.e1. PubMed ID: 22177993
[TBL] [Abstract][Full Text] [Related]
14. National cohort study showed that infants with Down's syndrome faced a high risk of hospitalisation for the respiratory syncytial virus.
Grut V; Söderström L; Naumburg E
Acta Paediatr; 2017 Sep; 106(9):1519-1524. PubMed ID: 28556255
[TBL] [Abstract][Full Text] [Related]
15. Burden of illness in infants and young children hospitalized for respiratory syncytial virus: A rapid review.
Wingert A; Pillay J; Moore DL; Guitard S; Vandermeer B; Dyson MP; Sinilaite A; Tunis M; Hartling L
Can Commun Dis Rep; 2021 Sep; 47(9):381-396. PubMed ID: 34650335
[TBL] [Abstract][Full Text] [Related]
16. Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis--a prospective birth-cohort study.
Bloemers BL; van Furth AM; Weijerman ME; Gemke RJ; Broers CJ; van den Ende K; Kimpen JL; Strengers JL; Bont LJ
Pediatrics; 2007 Oct; 120(4):e1076-81. PubMed ID: 17908728
[TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.
McLaurin KK; Farr AM; Wade SW; Diakun DR; Stewart DL
J Perinatol; 2016 Nov; 36(11):990-996. PubMed ID: 27490190
[TBL] [Abstract][Full Text] [Related]
18. Palivizumab use in infants with Down syndrome-report from the German Synagis™ Registry 2009-2016.
Simon A; Gehrmann S; Wagenpfeil G; Wagenpfeil S
Eur J Pediatr; 2018 Jun; 177(6):903-911. PubMed ID: 29651734
[TBL] [Abstract][Full Text] [Related]
19. Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based cohort study.
Kristensen K; Hjuler T; Ravn H; Simões EA; Stensballe LG
Clin Infect Dis; 2012 Mar; 54(6):810-7. PubMed ID: 22247121
[TBL] [Abstract][Full Text] [Related]
20. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
